Markets.com Logo

HRTX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.2896$
  • Previous Close
    1.32$
  • 52 Week Change
    1.64$
  • Day Range
    -0.03$
  • 52 Week High/Low
    1.04$ - 2.68$
  • Dividend Per Share
    --
  • Market cap
    202 M$
  • EPS
    -0.02
  • Beta
    1.155
  • Volume
    --

About

Heron Therapeutics, Inc. (HRTX.US) is a commercial-stage biotechnology company focused on developing and commercializing novel, best-in-class treatments to address unmet medical needs. Its primary focus is on pain management and oncology supportive care. Heron's products include ZYNRELEF, an extended-release local anesthetic, and SUSTOL, an injectable sustained-release formulation of granisetron used for the prevention of chemotherapy-induced nausea and vomiting. The company is based in San Diego, California.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Drug Trial Results: Positive clinical trial outcomes typically drive stock prices upward, while negative results can lead to a significant decline.

Regulatory Decisions: FDA approvals or rejections of Heron Therapeutics' drug applications heavily influence investor confidence and stock valuation.

Market Competition: The presence and success of competing drugs impact the potential market share and revenue for Heron's products, affecting stock price.

Financial Performance: Heron's revenue, profitability, and debt levels are crucial factors that determine investor sentiment and influence the stock price.

Overall Market Conditions: Broad economic trends and the performance of the biotechnology sector can impact Heron's stock price, irrespective of company-specific news.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--